Pohlmann Dominika, Zur Bonsen Lynn, Rübsam Anne, Pleyer Uwe
Universitäts-Augenklinik, Charité, Campus Virchow Klinikum - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Deutschland.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
Ophthalmologie. 2023 Apr;120(4):443-458. doi: 10.1007/s00347-023-01833-5. Epub 2023 Apr 6.
Noninfectious posterior uveitis (NPU) comprises a heterogeneous group of vision-threatening, immune-mediated ocular and systemic diseases. It is predominantly bilateral and recurrent and, if not treated properly, leads to severe tissue damage that threatens the eyesight. In industrialized countries ca. 10-20% of all cases of blindness are caused by NPU. An NPU can occur at any age but is most common between the ages of 20 and 50 years. Laboratory diagnostic and imaging procedures enable an increasingly better differentiation of the disease spectrum. This makes it possible to better assess the course and prognosis of individual disease entities. An increasing repertoire of systemic and intravitreal forms of treatment has already led to more favorable long-term treatment outcomes. It can be expected that further progress can be achieved with better knowledge of the pathophysiology of the different clinical disorders and appropriate, targeted treatment.
非感染性后葡萄膜炎(NPU)是一组异质性的、威胁视力的、免疫介导的眼部和全身性疾病。它主要为双侧性且易复发,若治疗不当,会导致严重的组织损伤,威胁视力。在工业化国家,约10%-20%的失明病例由NPU引起。NPU可发生于任何年龄,但最常见于20至50岁之间。实验室诊断和影像学检查程序能越来越精准地鉴别疾病谱。这使得更好地评估个体疾病实体的病程和预后成为可能。越来越多的全身和玻璃体腔内治疗方法已经带来了更有利的长期治疗效果。可以预期,随着对不同临床疾病病理生理学的深入了解以及采用适当的靶向治疗,将会取得进一步进展。